Bioniche Pharma manufactures over 20 pharmaceutical products, both branded and generic. Of Bioniche’s products, 11 are approved injectable products sold in the US and Canadian markets.  In more than 50 countries worldwide, Bioniche Pharma also sells branded products, which include Suplasyn^® and Cystistat^®.

Bioniche Pharma’s products serve a variety of niche markets and are sold to both the primary care and hospital markets. Bioniche Pharma currently operates out of 49,000 square feet of total facilities, including a newly constructed, state-of-the-art, 21,000 square foot manufacturing facility. Bioniche Pharma employs over 120 people and is based in Galway, Ireland.